1.
Clin Infect Dis
; 71(12): 3222-3225, 2020 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32445474
RESUMO
In a post hoc analysis of samples from an intrapartum azithromycin randomized clinical trial, we found that children whose mothers had been treated with the drug had higher prevalence of macrolide-resistance genes msr(A) and ermC at 28 days but not at 12 months. The 2 genes were positively associated in the nasopharynx. CLINICAL TRIALS REGISTRATION: NCT1800942.